Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.31−0.68 (-17.04%)
Close on Nov 17, 2026Market cap $30.72MP/E –Yield –
Exozymes operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Exozymes's operating cash flow for the twelve months ending Sep 30, 2026 was -$7.36M. For fiscal 2025 it was -$6.50M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.50M | – |
| FY2024 | Dec 31, 2024 | -$8.51M | – |
| FY2023 | Dec 31, 2023 | -$1.18M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.22M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.52M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.97M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.86M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.13M | -503.1% |
| Q4 FY2024 | Dec 31, 2024 | -$5.71M | – |
| Q3 FY2024 | Sep 30, 2024 | -$541.52K | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.54M | – |
| Q1 FY2024 | Mar 31, 2024 | $281.20K | – |
| Q4 FY2023 | Dec 31, 2023 | -$783.28K | – |
See a number that looks wrong?